{"id":735,"date":"2025-02-07T07:45:00","date_gmt":"2025-02-07T06:45:00","guid":{"rendered":"https:\/\/temporary.nolato.com\/mfn_news\/growth-with-sharply-improved-profit\/"},"modified":"2025-02-07T07:45:00","modified_gmt":"2025-02-07T06:45:00","slug":"growth-with-sharply-improved-profit","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/sv\/mfn_news\/growth-with-sharply-improved-profit\/","title":{"rendered":"Growth with sharply improved profit"},"content":{"rendered":"<div class=\"mfn-body\">\n<p><strong>Fourth quarter of 2024 in brief<\/strong><\/p>\n<ul>\n<li>Sales increased to SEK 2,382 million (2,252)<\/li>\n<li>Operating profit (EBITA) increased to SEK 240 million (177)<\/li>\n<li>EBITA margin of 10.1% (7.9)<\/li>\n<li>Profit after tax was SEK\u00a0163 million (125, excl. non-recurring items in 2023)<\/li>\n<li>Basic and diluted earnings per share increased to SEK 0.61 (0.46, excl. non-recurring items in 2023)<\/li>\n<li>Cash flow from operating activities increased to SEK 480 million (186)<\/li>\n<\/ul>\n<p>The Group\u2019s net sales, adjusted for currency, increased by 5% in the fourth quarter. Cash flow from operating activities was very strong in the quarter, amounting to a full SEK 480 million, thus further reinforcing our already solid financial position.<\/p>\n<p><strong>Business area performance<\/strong><\/p>\n<p>Medical Solutions sales amounted to SEK 1,359 million (1,300), giving an organic growth of 4%. Operating profit (EBITA) increased to SEK\u00a0152\u00a0million (129) and the EBITA margin to 11.2% (9.9). The Drug Delivery market area had healthy volumes for most of its products, while In vitro diagnostics (IVD) also delivered growth compared with low volumes in the same quarter last year.<\/p>\n<p>Engineered Solutions sales amounted to SEK 1,033 million (958); adjusted for currency, this was a sharp increase of 7%. Operating profit (EBITA) increased to SEK\u00a095\u00a0million (52) and the EBITA margin to 9.2% (5.4). All market areas, apart from automotive, displayed sales growth in the quarter. Materials (formerly EMC) increased organic sales by as much as 20%, supported by a recovery for network equipment within telecom. The business area\u2019s EBITA margin strengthened by a full 3.8 percentage points to 9.2%, thanks to improved volumes and efficiency.<\/p>\n<p><strong>Full year 2024 in brief<\/strong><\/p>\n<ul>\n<li>Sales increased to SEK 9,664 million (9,546)<\/li>\n<li>Operating profit (EBITA) rose to SEK\u00a0958 million (761, excl. non-recurring item in 2023)<\/li>\n<li>EBITA margin of 9.9% (8.0, excl. non-recurring item in 2023)<\/li>\n<li>Profit after tax was SEK\u00a0658 million (545, excl. non-recurring items in 2023)<\/li>\n<li>Basic and diluted earnings per share totaled SEK 2.44 (2.02, excl. non-recurring items in 2023)<\/li>\n<li>Cash flow from operating activities increased to SEK 1,377 million (781)<\/li>\n<li>The equity\/assets ratio was 59% (56) and net financial liabilities were SEK 671 million (895)<\/li>\n<\/ul>\n<p><strong>Comments from the CEO<\/strong><\/p>\n<p>Christer Wahlquist, President and CEO of Nolato AB, commented:<\/p>\n<p>We are maintaining our trend of organic growth quarter-on-quarter after having significantly changed our product mix over the past two years. At the same time, our EBITA margin rose to 10.1%, which is an improvement of 2.2 percentage points compared with last year. We thus see that our strategic price revisions and cost savings implemented to boost profitability are gradually bearing fruit.<\/p>\n<p>Nolato\u2019s overall strategy is to be the customer\u2019s first choice of innovative partner in sustainable design and production. We achieve this by having in-depth knowledge about, and a close relationship with, our customers. Together with our flexibility and production capacity on three continents, this enables us to serve major global and strategic customers. The foundation has been laid for increasingly profitable growth over time.<\/p>\n<p><strong>Dividend<\/strong><\/p>\n<p>At the Annual General Meeting, the Board of Directors and the President and CEO will propose an unchanged dividend of SEK\u00a01.50 per share (1.50), which corresponds to SEK 404 million (404). The pay-out ratio is 61% (74, excluding non-recurring items in 2023). The dividend yield was 2.8% on the share price as of December 31, 2024.<\/p>\n<p><strong>Annual General Meeting<\/strong><\/p>\n<p>The Annual General Meeting will be held on May 6, 2025 at 3 pm CET at Grevieparken, Sports Hall, H\u00e5larpsv\u00e4gen 14, Grevie, Sweden. Shareholders who would like to submit proposals to the Nomination Committee can contact the chairman of the Nomination Committee, Henrik Jorl\u00e9n, by e-mail at <a href=\"mailto:henrik.jorlen@gmail.com\" rel=\"noopener\" target=\"_blank\">henrik.jorlen@gmail.com<\/a> or by mail at Kommend\u00f6rsgatan 4, 269 77 Torekov, Sweden.<\/p>\n<p><strong>Capital Markets Day<\/strong><\/p>\n<p>Nolato will hold a Capital Markets Day on March 13, 2025 in central Stockholm. The Capital Markets Day will provide an opportunity for investors, analysts and the media to gain an update on the Company\u2019s position and operations as well as its strategy and goals. The event starts at 1 pm CET. Further information and a link for registration will be available at\u00a0<a href=\"http:\/\/www.nolato.com\/CMD\" rel=\"noopener\" target=\"_blank\">www.nolato.com\/CMD<\/a>.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-3b308a4d228b\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><\/p>\n<hr \/>\n<p><em>Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato\u2019s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. \u00a0<\/em><em><a href=\"https:\/\/www.nolato.com\/ir\" rel=\"noopener\" target=\"_blank\">www.nolato.com\/IR<\/a><\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-f7d2b6eafad2\">\n<p><strong class=\"mfn-heading-1\">Contact<\/strong><\/p>\n<hr \/>\n<p>For further information, please contact:<br \/>Christer Wahlquist, President and CEO, +46 (0)705 804848<br \/>Per-Ola Holmstr\u00f6m, CFO, +46 (0)705 763340, <a href=\"mailto:per-ola.holmstrom@nolato.com\" rel=\"noopener\" target=\"_blank\">per-ola.holmstrom@nolato.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-mar\">\n<p><em>This information is information that Nolato is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-02-07 07:45 CET.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><\/p>\n<hr \/>\n<p><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/b7de0738-324c-49b4-aa80-d40611aaa7b5\/nolato-q4-2024-year-end-report.pdf\" rel=\"noopener\" target=\"_blank\">Nolato Q4 2024 Year End Report<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fourth quarter of 2024 in brief Sales increased to SEK 2,382 million (2,252) Operating profit (EBITA) increased to SEK 240 million (177) EBITA margin of 10.1% (7.9) Profit after tax was SEK\u00a0163 million (125, excl. non-recurring items in 2023) Basic and diluted earnings per share increased to SEK 0.61 (0.46, excl. non-recurring items in 2023)&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/sv\/mfn_news\/growth-with-sharply-improved-profit\/\">Continue reading <span class=\"screen-reader-text\">Growth with sharply improved profit<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-735","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-report-interim-q4","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"sv","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news\/735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/media?parent=735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}